Trevi Therapeutics

-$0.07 (-3.21%) As of 6:40 PM UTC today

Why Robinhood?

You can buy or sell TRVI and other stocks, options, and ETFs commission-free!

About TRVI

Trevi Therapeutics, Inc. Common Stock, also called Trevi Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the development and commercialization Haduvio to treat serious neurologically mediated conditions.

CEO
Jennifer L. Good
Employees
22
Headquarters
New Haven, Connecticut
Founded
2011

TRVI Key Statistics

Market Cap
42.05M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
147.01K
High Today
$2.21
Low Today
$2.10
Open Price
$2.21
Volume
30.59K
52 Week High
$8.50
52 Week Low
$1.94

TRVI Earnings

-$0.52
-$0.35
-$0.17
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
—
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure